Study Examines Kidney Injury in Patients Taking Immunotherapy Cancer Medications

In patients taking immune checkpoint inhibitors as a treatment for cancer, 17% experienced acute kidney injury (AKI), 8% experienced sustained AKI, and 3% had potential immune checkpoint inhibitor–related AKI.
• Use of proton pump inhibitors, which are commonly used to treat stomach ulcers or acid reflux, was associated with a higher risk of experiencing sustained AKI.

Jay Golden named 14th President of Wichita State University

Wichita State University’s new President, Jay Golden, is a leading researcher in environmental sustainability and an advocate for applied learning and economic development.

Golden will become Wichita State’s 14th President in January 2020 during a period of rapid growth for the university and changes in higher education. He brings a background as a leading thinker and national leader on environmental sustainability, applied learning and economic development.

HOW MEASLES WIPES OUT THE BODY’S IMMUNE MEMORY

Study shows measles wipes out 20 to 50 percent of antibodies against an array of viruses and bacteria, depleting a child’s previous immunity
Measles-ravaged immune system must “relearn” how to protect the body against infections
Study details mechanism and scope of this measles-induced “immune amnesia”
Findings underscore importance of measles vaccination, suggesting those infected with measles may benefit from booster shots of all previous childhood vaccines

SCREENING TOOL ADMINISTERED IN PEDIATRIC ER ACCURATELY GAUGES SUICIDE RISK

A suicide risk screening tool that Johns Hopkins Medicine implemented in its pediatric emergency department six years ago appears to provide an accurate gauge of which youth are most vulnerable and has identified more than 2,000 patients who might benefit from mental health treatment and resources, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Medicine

Potential Genetic Markers of Multiple Sclerosis Severity

In a bid to determine factors linked to the most debilitating forms of multiple sclerosis (MS), Johns Hopkins Medicine researchers say they have identified three so-called “complement system” genes that appear to play a role in MS-caused vision loss. The researchers were able to single out these genes — known to be integral in the development of the brain and immune systems — by using DNA from MS patients along with high-tech retinal scanning.

Common early sign of cardiovascular disease also may indicate cancer risk, study finds

A Mayo Clinic-led study involving 488 cardiac patients whose cases were followed for up to 12 years finds that microvascular endothelial dysfunction, a common early sign of cardiovascular disease, is associated with a greater than twofold risk of cancer.

The study, published in the European Journal of Preventive Cardiology, finds that microvascular endothelial dysfunction may be a useful marker for predicting risk of solid-tumor cancer, in addition to its known ability to predict more advanced cardiovascular disease, says Amir Lerman, M.D., a Mayo Clinic cardiologist and the study’s senior author.

LLNL leads multi-institutional team in modeling protein interactions tied to cancer

Computational scientists, biophysicists and statisticians from Lawrence Livermore National Laboratory (LLNL) and Los Alamos National Laboratory (LANL) are leading a massive multi-institutional collaboration that has developed a machine learning-based simulation for next-generation supercomputers capable of modeling protein interactions and mutations that play a role in many forms of cancers.

For Patients with Sepsis, an Infectious Disease Expert May Reduce the Risk of Death

When people with severe sepsis, an extreme overreaction by the body to a serious infection, come to the emergency room (ER), they require timely, expert care to prevent organ failure and even death. When that care includes the early involvement of an infectious disease (ID) specialist, patient mortality can be reduced by as much as 40 percent, according to a new retrospective, single-center study published in Open Forum Infectious Diseases.

A deadly fungus is wiping out North American bats while Eurasian bats have learned to live with it. An international team wants to know why.

Wildlife disease ecologist Jeff Foster of Northern Arizona University is partnering with researchers throughout the world to study the spread of white-nose syndrome, which was discovered in North America in 2006. Researchers believed it migrated from Europe and has continued moving west.